| The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery BE Schaafsma, JSD Mieog, M Hutteman, JR Van der Vorst, PJK Kuppen, ... Journal of surgical oncology 104 (3), 323-332, 2011 | 911 | 2011 |
| Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer R Salazar, P Roepman, G Capella, V Moreno, I Simon, C Dreezen, ... J clin oncol 29 (1), 17-24, 2011 | 645 | 2011 |
| Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients EM de Kruijf, JGH van Nes, CJH van de Velde, H Putter, VT Smit, ... Breast cancer research and treatment 125, 687-696, 2011 | 332 | 2011 |
| Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer JSD Mieog, SL Troyan, M Hutteman, KJ Donohoe, JR Van Der Vorst, ... Annals of surgical oncology 18, 2483-2491, 2011 | 317 | 2011 |
| HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients EM de Kruijf, A Sajet, JGH van Nes, R Natanov, H Putter, VT Smit, ... The Journal of Immunology 185 (12), 7452-7459, 2010 | 314 | 2010 |
| The CpG island methylator phenotype (CIMP) in colorectal cancer EN Mojarad, PJK Kuppen, HA Aghdaei, MR Zali Gastroenterology and hepatology from bed to bench 6 (3), 120, 2013 | 300 | 2013 |
| Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis AG Menon, CM Janssen-van Rhijn, H Morreau, H Putter, RAEM Tollenaar, ... Laboratory investigation 84 (4), 493-501, 2004 | 290 | 2004 |
| NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity PA Albertsson, PH Basse, M Hokland, RH Goldfarb, JF Nagelkerke, ... Trends in immunology 24 (11), 603-609, 2003 | 289 | 2003 |
| Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients E Bastiaannet, GJ Liefers, AJM De Craen, PJK Kuppen, W Van De Water, ... Breast cancer research and treatment 124, 801-807, 2010 | 281 | 2010 |
| Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization MH Sandel, AR Dadabayev, AG Menon, H Morreau, CJM Melief, ... Clinical Cancer Research 11 (7), 2576-2582, 2005 | 243 | 2005 |
| TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis L Zhang, F Zhou, AG de Vinuesa, EM de Kruijf, WE Mesker, L Hui, ... Molecular cell 51 (5), 559-572, 2013 | 233 | 2013 |
| High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue A Ly, A Buck, B Balluff, N Sun, K Gorzolka, A Feuchtinger, KP Janssen, ... Nature protocols 11 (8), 1428-1443, 2016 | 228 | 2016 |
| The immunological consequences of photodynamic treatment of cancer, a literature review FH van Duijnhoven, RIJM Aalbers, JP Rovers, OT Terpstra, PJK Kuppen Immunobiology 207 (2), 105-113, 2003 | 225 | 2003 |
| Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer FM Speetjens, PJK Kuppen, MJP Welters, F Essahsah, ... Clinical Cancer Research 15 (3), 1086-1095, 2009 | 222 | 2009 |
| The role of natural killer T cells in cancer—a phenotypical and functional approach D Krijgsman, M Hokland, PJK Kuppen Frontiers in immunology 9, 367, 2018 | 208 | 2018 |
| Specific tumor-cell killing with adenovirus vectors containing the apoptin gene AM Pietersen, MM Van der Eb, HJ Rademaker, DJM Van den Wollenberg, ... Gene Therapy 6 (5), 882-892, 1999 | 186 | 1999 |
| Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I–II colon cancer patients WE Mesker, GJ Liefers, J Junggeburt, GW van Pelt, P Alberici, ... Analytical Cellular Pathology 31 (3), 169-178, 2009 | 182 | 2009 |
| Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients ECM Zeestraten, MS Reimers, S Saadatmand, JWT Dekker, GJ Liefers, ... British journal of cancer 110 (2), 459-468, 2014 | 177 | 2014 |
| Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry A Trinh, K Trumpi, F De Sousa E Melo, X Wang, JH De Jong, E Fessler, ... Clinical cancer research 23 (2), 387-398, 2017 | 165 | 2017 |
| NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study EM de Kruijf, A Sajet, JGH van Nes, H Putter, VT Smit, RA Eagle, I Jafferji, ... BMC cancer 12, 1-12, 2012 | 161 | 2012 |
